These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 32735046)
1. Are common delirium assessment tools appropriate for evaluating delirium at the end of life in cancer patients? Uchida M; Morita T; Akechi T; Yokomichi N; Sakashita A; Hisanaga T; Matsui T; Ogawa A; Yoshiuchi K; Iwase S; Psychooncology; 2020 Nov; 29(11):1842-1849. PubMed ID: 32735046 [TBL] [Abstract][Full Text] [Related]
2. Communication Capacity Scale and Agitation Distress Scale to measure the severity of delirium in terminally ill cancer patients: a validation study. Morita T; Tsunoda J; Inoue S; Chihara S; Oka K Palliat Med; 2001 May; 15(3):197-206. PubMed ID: 11407191 [TBL] [Abstract][Full Text] [Related]
3. Drug therapy for delirium in terminally ill adults. Finucane AM; Jones L; Leurent B; Sampson EL; Stone P; Tookman A; Candy B Cochrane Database Syst Rev; 2020 Jan; 1(1):CD004770. PubMed ID: 31960954 [TBL] [Abstract][Full Text] [Related]
4. Visualizing How to Use Antipsychotics for Agitated Delirium in the Last Days of Life. Imai K; Morita T; Mori M; Kiuchi D; Yokomichi N; Miwa S; Okamoto S; Yamauchi T; Naito AS; Matsuda Y; Maeda I; Sugano K; Ikenaga M; Inoue S; Satomi E J Pain Symptom Manage; 2023 Jun; 65(6):479-489. PubMed ID: 36682673 [TBL] [Abstract][Full Text] [Related]
5. A Novel Objective Measure for Terminal Delirium: Activity Scores Measured by a Sheet-Type Sensor. Otani H; Yokomichi N; Imai K; Toyota S; Yamauchi T; Miwa S; Yuasa M; Okamoto S; Kogure T; Inoue S; Morita T J Pain Symptom Manage; 2024 Sep; 68(3):246-254. PubMed ID: 38810949 [TBL] [Abstract][Full Text] [Related]
6. Delirium, agitation, and symptom distress within the final seven days of life among cancer patients receiving hospice care. de la Cruz M; Noguera A; San Miguel-Arregui MT; Williams J; Chisholm G; Bruera E Palliat Support Care; 2015 Apr; 13(2):211-6. PubMed ID: 24556057 [TBL] [Abstract][Full Text] [Related]
7. The Rotterdam Elderly Pain Observation Scale (REPOS) is reliable and valid for non-communicative end-of-life patients. Masman AD; van Dijk M; van Rosmalen J; Baar FPM; Tibboel D; Boerlage AA BMC Palliat Care; 2018 Feb; 17(1):34. PubMed ID: 29466977 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of Oral Risperidone, Haloperidol, or Placebo for Symptoms of Delirium Among Patients in Palliative Care: A Randomized Clinical Trial. Agar MR; Lawlor PG; Quinn S; Draper B; Caplan GA; Rowett D; Sanderson C; Hardy J; Le B; Eckermann S; McCaffrey N; Devilee L; Fazekas B; Hill M; Currow DC JAMA Intern Med; 2017 Jan; 177(1):34-42. PubMed ID: 27918778 [TBL] [Abstract][Full Text] [Related]
9. Safety and effectiveness of antipsychotic medication for delirium in patients with advanced cancer: A large-scale multicenter prospective observational study in real-world palliative care settings. Maeda I; Ogawa A; Yoshiuchi K; Akechi T; Morita T; Oyamada S; Yamaguchi T; Imai K; Sakashita A; Matsumoto Y; Uemura K; Nakahara R; Iwase S; Gen Hosp Psychiatry; 2020; 67():35-41. PubMed ID: 32950826 [TBL] [Abstract][Full Text] [Related]
10. Clinical Assessment and Management of Delirium in the Palliative Care Setting. Bush SH; Tierney S; Lawlor PG Drugs; 2017 Oct; 77(15):1623-1643. PubMed ID: 28864877 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of palliative sedation therapy: a multicenter, prospective, observational study conducted on specialized palliative care units in Japan. Morita T; Chinone Y; Ikenaga M; Miyoshi M; Nakaho T; Nishitateno K; Sakonji M; Shima Y; Suenaga K; Takigawa C; Kohara H; Tani K; Kawamura Y; Matsubara T; Watanabe A; Yagi Y; Sasaki T; Higuchi A; Kimura H; Abo H; Ozawa T; Kizawa Y; Uchitomi Y; J Pain Symptom Manage; 2005 Oct; 30(4):320-8. PubMed ID: 16256896 [TBL] [Abstract][Full Text] [Related]
12. Delirium diagnosis, screening and management. Lawlor PG; Bush SH Curr Opin Support Palliat Care; 2014 Sep; 8(3):286-95. PubMed ID: 25004177 [TBL] [Abstract][Full Text] [Related]
13. Low-Dose Trazodone for Delirium in Patients with Cancer Who Received Specialist Palliative Care: A Multicenter Prospective Study. Maeda I; Inoue S; Uemura K; Tanimukai H; Hatano Y; Yokomichi N; Amano K; Tagami K; Yoshiuchi K; Ogawa A; Iwase S; J Palliat Med; 2021 Jun; 24(6):914-918. PubMed ID: 33577386 [No Abstract] [Full Text] [Related]
14. Agitation and delirium at the end of life: "We couldn't manage him". Breitbart W; Alici Y JAMA; 2008 Dec; 300(24):2898-910, E1. PubMed ID: 19109118 [TBL] [Abstract][Full Text] [Related]
15. Comparison of Pharmacological Treatments for Agitated Delirium in the Last Days of Life. Kawashima N; Yokomichi N; Morita T; Yabuki R; Hisanaga T; Imai K; Hirose Y; Shimokawa M; Miwa S; Yamauchi T; Okamoto S; Satomi E J Pain Symptom Manage; 2024 May; 67(5):441-452.e3. PubMed ID: 38355071 [TBL] [Abstract][Full Text] [Related]
16. Reversibility of delirium in Ill-hospitalized cancer patients: Does underlying etiology matter? Matsuda Y; Maeda I; Morita T; Yamauchi T; Sakashita A; Watanabe H; Kaneishi K; Amano K; Iwase S; Ogawa A; Yoshiuchi K; Cancer Med; 2020 Jan; 9(1):19-26. PubMed ID: 31696671 [TBL] [Abstract][Full Text] [Related]
17. Propofol-Based Palliative Sedation to Treat Antipsychotic-Resistant Agitated Delirium. Covarrubias-Gómez A; López Collada-Estrada M J Pain Palliat Care Pharmacother; 2017; 31(3-4):190-194. PubMed ID: 28506099 [TBL] [Abstract][Full Text] [Related]
18. Delirium prevention in terminal cancer: assessment of a multicomponent intervention. Gagnon P; Allard P; Gagnon B; Mérette C; Tardif F Psychooncology; 2012 Feb; 21(2):187-94. PubMed ID: 22271539 [TBL] [Abstract][Full Text] [Related]
19. Influence of Sedation Level and Ventilation Status on the Diagnostic Validity of Delirium Screening Tools in the ICU-An International, Prospective, Bi-Center Observational Study (IDeAS). Nacul FE; Paul N; Spies CD; Sechting H; Hecht T; Dullinger JS; Piper SK; Luetz A; Balzer FS; Wernecke KD; Sa AK; Barros Ferreira da Costa C; Eymold L; Chenitir C; Weiss B Medicina (Kaunas); 2020 Aug; 56(8):. PubMed ID: 32823781 [No Abstract] [Full Text] [Related]
20. The minimal clinically important difference of the Richmond Agitation-Sedation Scale in patients with cancer with agitated delirium. Hui D; Hess K; Dibaj SS; Arthur J; Dev R; Dalal S; Reddy S; Bruera E Cancer; 2018 May; 124(10):2246-2252. PubMed ID: 29469951 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]